|
|
1.
|
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT. MedStar authors:
Year: 2022
Citation: - Circulation. 146(18):1344-1356, 2022 Nov.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Babar I, Baird-Zars V, Barnett CF, Berg DD, Bohula EA, Chaudhry SP, Chopra A, Connors JM, COVID-PACT Investigators, Ginete W, Ieong MH, Katz JN, Kim EY, Kuder JF, Lopes MS, Mazza E, McLean D, Morrow DA, Mosier JM, Moskowitz A, Murphy SA, O'Donoghue ML, Park JG, Prasad R, Ruff CT, Sabatine MS, Shahrour MN, Sinha SS, Van Diepen S, Wiviott SD, Zainea M
|
|
|
3.
|
Catheter-directed thrombolysis vs. anticoagulation for the prevention and treatment of post-thrombotic syndrome in deep vein thrombosis: An updated systematic review and meta-analysis of randomized trials. MedStar authors:
- Bikakis, Iosif
- Jonnalagadda, Anil K
Year: 2019
Citation: - Phlebology. 34(10):675-682, 2019 Dec.
Institution:
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
Department: - Medicine/General Internal Medicine
Medline publication type:
All authors: - Archontakis-Barakakis P, Bakoyiannis C, Bikakis I, Faillace RT, Jonnalagadda AK, Kokkinidis DG, Mastoris I, Palaiodimos L, Papanastasiou CA, Schizas D
|
